We are developing a type of non-invasive neurotechnology called an EEG (electroencephalogram) using technological advances in neuroscience and nanotechnology.

CalgaryPulse is a living AI simulation of Calgary's economy that lets any citizen click their property to see exactly where their tax dollars go, ask policy questions in plain English and watch the city simulate the answer across 500,000 real properties, and explore AI-powered recommendations for reviving vacant downtown buildings
turning Calgary's 30% office vacancy crisis from an invisible problem into an interactive, solvable one.

We are developing a programmable outer membrane vesicle (OMV) loading platform to address major limitations in current OMV biomanufacturing, including low loading yields, poor scalability, and inefficient cargo incorporation. These challenges are especially critical in combating antimicrobial resistance (AMR), where biofilms formed by ESKAPE pathogens prevent effective antimicrobial delivery and accelerate resistance development. Given that the non-specific nature of conventional antibiotic delivery further promotes the development of multi-drug resistant bacteria, improving targeted drug delivery systems is essential in preventing the worsening of AMR.
Our platform leverages OMVs as a natural delivery system capable of penetrating biofilms, protecting therapeutic cargo from degradation, and bypassing porin-mediated resistance mechanisms. Using vesicle nucleating peptide (VNp)-based engineering, we aim to selectively package antimicrobial peptides into OMVs to target ESKAPE pathogens. By creating a scalable and modular OMV delivery platform, our project aims to enable targeted antimicrobial therapies against resistant pathogens while supporting broader applications in therapeutics, vaccines, and biotechnology.

Our project bridges a critical gap in skin cancer prevention by transforming complex UV data into a creative, consumer-facing product: a colour-changing pigment-producing substance tested with bacteria applied to the skin using a model like a henna pen to make monitoring sun damage an intuitive and fun life-saving habit.

Project90 SOCKS team develops an ultra-thin smart sock with embedded pressure sensors to give prosthetists real-time 3D pressure maps during prosthetic socket fitting. This addresses the #1 patient complaint—poor socket fit—by replacing subjective visual inspections with objective data, potentially cutting clinic visits in half.

SpineSense is a project that provides a real-time brace tension sensor for scoliosis patients. Using strain gauges and a companion mobile app, our device integrates directly onto the strap of a scoliosis brace and continuously monitors whether the correct force is being applied, giving patients, parents, and clinicians meaningful data for the first time. We are pursuing pilot testing in partnership with Cascade Orthotics.

Ice rinks are a cultural and recreational cornerstone in Canada, supporting over 800,000 registered skaters, hockey players, and curlers. Maintaining rink surface temperatures between -4 and -8 °C requires energy-intensive refrigeration systems, making these facilities among the largest municipal energy consumers. Statistics indicate that, for each degree increase in surface temperature, approximately 5% of energy consumption can be saved. This study proposes transforming E. coli with modified inaZ genes, native to Pseudomonas syringae, to produce ice-nucleating proteins (INPs) that promote ice formation at higher temperatures. In this study, E. coli will be engineered with two variations of the inaZ gene where the N-terminal domain has been truncated, enabling intracellular protein production. Protein expression of the two variants has been successfully achieved, and ongoing work focuses on increasing protein yield for functional assays. In parallel, molecular dynamics (MD) simulations of INP-water interactions demonstrated the formation of ice lattice structures, with ~600 hydrogen bonds forming over 5 μs. Experimentation on commercial INPs identified a minimum effective nucleation concentration of 0.250 g L⁻¹, capable of inducing ice formation at temperatures as high as -2°C. To evaluate applicability, 3D-printed rink models were developed to simulate rink conditions and assess nucleation efficiency through ongoing functional assays.

Synfera is developing a shelf-stable, universally compatible oxygen therapeutic designed to reduce reliance on donated blood. By leveraging synthetic biology and recombinant biomanufacturing, we aim to create a scalable solution that addresses blood shortages, cold-chain limitations, and supply constraints. Our goal is to expand reliable oxygen delivery in emergency, rural, and resource-limited settings.

Loneliness contributes to over 871,000 deaths annually, while 1.8 billion adults remain insufficiently active, yet social media platforms are engineered to maximize screen time, not real-world connection. Synq is a behavior-designed mobile platform that inverts this model. No feed, no ads, no passive scrolling. Instead of optimizing for attention, Synq optimizes for participation: users discover nearby activity sessions, form friendships through shared action, and document verified Moments that confirm they showed up. Synq does not compete with social media. It reconstructs what social media displaced.

A non-invasive, reusable DNA-based electrochemical biosensor for Alzheimer's Disease biomarkers.